Bank of New York Mellon’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $626K | Buy |
+135,557
| New | +$513K | ﹤0.01% | 3638 |
|
|
2025
Q2 | – | Sell |
-156,787
| Closed | -$199K | – | 4217 |
|
|
2025
Q1 | $199K | Sell |
156,787
-9,335
| -6% | -$24.4K | ﹤0.01% | 3889 |
|
|
2024
Q4 | $540K | Sell |
166,122
-52,439
| -24% | -$189K | ﹤0.01% | 3482 |
|
|
2024
Q3 | $719K | Sell |
218,561
-43,383
| -17% | -$169K | ﹤0.01% | 3314 |
|
|
2024
Q2 | $1.11M | Buy |
261,944
+12,237
| +5% | +$119K | ﹤0.01% | 3132 |
|
|
2024
Q1 | $3.68M | Sell |
249,707
-15,365
| -6% | -$232K | ﹤0.01% | 2462 |
|
|
2023
Q4 | $2.55M | Buy |
265,072
+66,225
| +33% | +$458K | ﹤0.01% | 2709 |
|
|
2023
Q3 | $927K | Buy |
198,847
+744
| +0.4% | +$3.7K | ﹤0.01% | 3200 |
|
|
2023
Q2 | $1.06M | Buy |
198,103
+170
| +0.1% | +$1.05K | ﹤0.01% | 3166 |
|
|
2023
Q1 | $1.42M | Sell |
197,933
-9,197
| -4% | -$55.4K | ﹤0.01% | 2982 |
|
|
2022
Q4 | $1.39M | Sell |
207,130
-3,849
| -2% | -$21.1K | ﹤0.01% | 3040 |
|
|
2022
Q3 | $730K | Buy |
210,979
+20,094
| +11% | +$76.9K | ﹤0.01% | 3363 |
|
|
2022
Q2 | $563K | Sell |
190,885
-7,597
| -4% | -$39.9K | ﹤0.01% | 3519 |
|
|
2022
Q1 | $1.75M | Buy |
198,482
+908
| +0.5% | +$10K | ﹤0.01% | 3012 |
|
|
2021
Q4 | $3.17M | Buy |
197,574
+468
| +0.2% | +$8.81K | ﹤0.01% | 2717 |
|
|
2021
Q3 | $4.13M | Buy |
197,106
+22,018
| +13% | +$530K | ﹤0.01% | 2586 |
|
|
2021
Q2 | $4.7M | Sell |
175,088
-111,363
| -39% | -$3.26M | ﹤0.01% | 2527 |
|
|
2021
Q1 | $9.12M | Buy |
286,451
+60,818
| +27% | +$1.48M | ﹤0.01% | 2134 |
|
|
2020
Q4 | $5.16M | Buy |
225,633
+11,417
| +5% | +$263K | ﹤0.01% | 2344 |
|
|
2020
Q3 | $5.4M | Buy |
214,216
+4,110
| +2% | +$112K | ﹤0.01% | 2172 |
|
|
2020
Q2 | $5.87M | Buy |
210,106
+1,807
| +0.9% | +$31.4K | ﹤0.01% | 2133 |
|
|
2020
Q1 | $1.21M | Sell |
208,299
-2,704
| -1% | -$24.6K | ﹤0.01% | 2841 |
|
|
2019
Q4 | $2.3M | Buy |
211,003
+22,136
| +12% | +$219K | ﹤0.01% | 2744 |
|
|
2019
Q3 | $2.41M | Sell |
188,867
-11,422
| -6% | -$165K | ﹤0.01% | 2653 |
|
|
2019
Q2 | $3.4M | Buy |
200,289
+32,380
| +19% | +$556K | ﹤0.01% | 2519 |
|
|
2019
Q1 | $3.02M | Buy |
167,909
+6,564
| +4% | +$113K | ﹤0.01% | 2575 |
|
|
2018
Q4 | $2.05M | Sell |
161,345
-21
| -0% | -$352 | ﹤0.01% | 2711 |
|
|
2018
Q3 | $3.46M | Buy |
161,366
+712
| +0.4% | +$15.2K | ﹤0.01% | 2567 |
|
|
2018
Q2 | $3.32M | Sell |
160,654
-5,243
| -3% | -$118K | ﹤0.01% | 2584 |
|
|
2018
Q1 | $4.17M | Buy |
165,897
+12,776
| +8% | +$310K | ﹤0.01% | 2442 |
|
|
2017
Q4 | $2.91M | Sell |
153,121
-8,209
| -5% | -$153K | ﹤0.01% | 2628 |
|
|
2017
Q3 | $2.98M | Buy |
161,330
+1,491
| +0.9% | +$25.8K | ﹤0.01% | 2596 |
|
|
2017
Q2 | $2.8M | Buy |
159,839
+25,279
| +19% | +$482K | ﹤0.01% | 2646 |
|
|
2017
Q1 | $2.5M | Sell |
134,560
-3,992
| -3% | -$77K | ﹤0.01% | 2712 |
|
|
2016
Q4 | $2.83M | Buy |
138,552
+7,009
| +5% | +$176K | ﹤0.01% | 2646 |
|
|
2016
Q3 | $3.93M | Sell |
131,543
-7,314
| -5% | -$218K | ﹤0.01% | 2358 |
|
|
2016
Q2 | $3.75M | Buy |
138,857
+7,365
| +6% | +$166K | ﹤0.01% | 2360 |
|
|
2016
Q1 | $2.46M | Sell |
131,492
-4,362
| -3% | -$83K | ﹤0.01% | 2537 |
|
|
2015
Q4 | $4.21M | Sell |
135,854
-8,116
| -6% | -$247K | ﹤0.01% | 2324 |
|
|
2015
Q3 | $3.08M | Buy |
143,970
+3,544
| +3% | +$111K | ﹤0.01% | 2495 |
|
|
2015
Q2 | $5.33M | Buy |
140,426
+14,039
| +11% | +$461K | ﹤0.01% | 2314 |
|
|
2015
Q1 | $3.96M | Buy |
126,387
+24,669
| +24% | +$836K | ﹤0.01% | 2447 |
|
|
2014
Q4 | $3.57M | Buy |
101,718
+18,745
| +23% | +$467K | ﹤0.01% | 2492 |
|
|
2014
Q3 | $1.74M | Buy |
82,973
+9,503
| +13% | +$197K | ﹤0.01% | 2979 |
|
|
2014
Q2 | $1.6M | Buy |
73,470
+46,066
| +168% | +$968K | ﹤0.01% | 3036 |
|
|
2014
Q1 | $763K | Buy |
27,404
+7,525
| +38% | +$266K | ﹤0.01% | 3413 |
|
|
2013
Q4 | $545K | Buy |
+19,879
| New | +$520K | ﹤0.01% | 3554 |
|
Other funds holding MGNX
WA
PA
PAM
SO
Bank of New York Mellon's MGNX Position: Q2 2026 in Review
Bank of New York Mellon opened a new position in MacroGenics (MGNX) in Q2 2026: 135,557 shares worth $626K. The stake represents ﹤0.01% of the portfolio and ranks #3638 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in MGNX as recently as Q1 2025.
Bank of New York Mellon first reported a position in MGNX in Q4 2013 and has held it in 47 quarters since. The position peaked at $9.12M in Q1 2021. 39 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.
- Bank of New York Mellon held 135,557 shares of MacroGenics worth $626K as of Q2 2026.
- MacroGenics was a new Bank of New York Mellon position in Q2 2026.
- MacroGenics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3638 holding.
- Bank of New York Mellon first reported a position in MacroGenics in Q4 2013 and has held it in 47 quarters since.
- Bank of New York Mellon's MacroGenics position peaked at $9.12M in Q1 2021.
- 39 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.